Today: 27 June 2026
Akamai Stock Is Jumping Before Earnings: The API Security Bet Investors Are Watching

Akamai Stock Is Jumping Before Earnings: The API Security Bet Investors Are Watching

CAMBRIDGE, Massachusetts, May 5, 2026, 15:04 EDT

Akamai Technologies jumped roughly 10% Tuesday, buoyed by the launch of fresh products aimed at helping clients spot and address vulnerabilities in APIs—the digital pipelines letting different software talk. The announcement comes just two days ahead of Akamai’s first-quarter earnings release.

Timing is crucial here. Akamai wants investors to see that its security and cloud segments are ready to drive growth, stepping up as the legacy content-delivery business runs into tougher competition and pricing pressure. Shares were changing hands around $116 this afternoon, putting Akamai’s market cap close to $16.8 billion.

Akamai set its Q1 earnings call for Thursday, May 7, at 4:30 p.m. ET, with management signaling that financial guidance could be on the table. The timing drops the new product launch just ahead of a results day, when investors will want answers on cloud infrastructure spend, security appetite, and margin trends.

The company is rolling out its Security Posture Center, aiming to organize scattered API security findings into measurable controls. Code-to-runtime mapping is part of the offering, letting users trace live API traffic directly to code repositories, files, and even the last people to commit changes. Oz Golan, Akamai’s vice president of API security, described the product as a way to define “what ‘secure’ looks like,” saying it bridges the gap between security teams and developers. Akamai

As companies roll out more AI-based apps, API security is grabbing fresh attention. Akamai’s 2026 API security study found 87% of surveyed firms had dealt with API-related incidents, yet just 23% could actually pinpoint which APIs exposed sensitive data. APIs linked to AI topped the list of incident types, according to the company.

This wasn’t just Akamai’s surge. Cloudflare, which competes in edge security and content delivery, tacked on roughly 10%. Fastly, another player in content delivery and edge computing, popped more than 18%. Datadog edged down, underscoring the patchy action among cloud and software stocks.

Last month, Oppenheimer bumped its price target on Akamai up to $130 from $115 while maintaining its outperform call, a TipRanks report showed. The analysts pointed to revenue tracking near the top of guidance, highlighting customer demand for Guardicore, Noname security modules, and Akamai’s expanding cloud infrastructure features.

Thursday’s results land against a patchwork financial backdrop. For the fourth quarter, Akamai posted $1.095 billion in revenue, a 7% rise. Security sales climbed 11%, cloud infrastructure shot up 45%. But delivery revenue—its core content delivery business—dropped 2%.

But cost and execution loom as real risks. For 2026, Akamai is forecasting revenue between $4.4 billion and $4.55 billion, with capital expenditures pegged at 23% to 26% of revenue—a sizable outlay if cloud and AI-driven growth drags. The company’s adjusted earnings guidance has investors zeroing in on whether newer segments can pick up the slack in delivery, all while maintaining margins.

Right now, Akamai’s new API tools sharpen its earnings pitch—security, developer workflow, and a wider net for AI risk. On Thursday, though, management faces a tougher bar: putting figures to the narrative.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Strategy Stock Drops Nearly 25% Amid Crypto Market Turmoil
    June 27, 2026, 10:34 AM EDT. Strategy (MSTR) shares plunged 24.80% last week, triggering fresh concern across cryptocurrency investors. The fall added pressure on the market amid broader crypto volatility. Experts attribute the slide to amplified fears regarding bitcoin and other digital assets, with investors pulling back. Strategy, heavily linked to crypto through its bitcoin holdings, remains a bellwether for the sector. The drop underscores ongoing instability in digital asset markets and heightened sensitivity to regulatory and market shifts.

Latest articles

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
US Stock Market Today: Nasdaq Hits Record as Oil Retreats and Earnings Lift Wall Street
Previous Story

US Stock Market Today: Nasdaq Hits Record as Oil Retreats and Earnings Lift Wall Street

Pool Corporation Stock Sinks as CEO Exit and Investor Day Delay Raise Fresh Doubts
Next Story

Pool Corporation Stock Sinks as CEO Exit and Investor Day Delay Raise Fresh Doubts

Go toTop